220 related articles for article (PubMed ID: 10372835)
21. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
[TBL] [Abstract][Full Text] [Related]
22. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
23. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of secondary hyperparathyroidism.
Silver J; Kilav R; Sela-Brown A; Naveh-Many T
Pediatr Nephrol; 2000 Jul; 14(7):626-8. PubMed ID: 10912531
[TBL] [Abstract][Full Text] [Related]
26. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
27. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
Fukagawa M; Kurokawa K
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():96-9. PubMed ID: 1338454
[TBL] [Abstract][Full Text] [Related]
28. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
Schömig M; Ritz E
Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
[TBL] [Abstract][Full Text] [Related]
29. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
30. New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure.
Silver J; Moallem E; Kilav R; Epstein E; Sela A; Naveh-Many T
Nephrol Dial Transplant; 1996; 11 Suppl 3():2-5. PubMed ID: 8840303
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of secondary hyperparathyroidism.
Slatopolsky E; Brown A; Dusso A
Kidney Int Suppl; 1999 Dec; 73():S14-9. PubMed ID: 10633458
[TBL] [Abstract][Full Text] [Related]
32. Effects of 1,25- and 24,25-dihydroxycholecalciferol on parathyroid hormone release from human parathyroid cells in vitro.
Rudberg C; Akerström G; Johansson H; Ljunghall S; Malmaeus J; Wide L
Acta Endocrinol (Copenh); 1984 Mar; 105(3):354-9. PubMed ID: 6608201
[TBL] [Abstract][Full Text] [Related]
33. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
34. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
35. [Significance of point of no return in therapeutic strategy for treatment of renal osteodystrophy; from histopathological findings].
Koiwa F; Hirose M
Clin Calcium; 2004 Sep; 14(9):46-52. PubMed ID: 15577109
[TBL] [Abstract][Full Text] [Related]
36. [Role of vitamin D in the pathogenesis of renal osteodystrophy].
Nakanishi S; Fukagawa M
Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104
[TBL] [Abstract][Full Text] [Related]
37. Regulation of parathyroid function in chronic renal failure.
Rodriguez M; Cañadillas S; Lopez I; Aguilera-Tejero E; Almaden Y
J Bone Miner Metab; 2006; 24(2):164-8. PubMed ID: 16502126
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
Naveh-Many T; Rahamimov R; Livni N; Silver J
J Clin Invest; 1995 Oct; 96(4):1786-93. PubMed ID: 7560070
[TBL] [Abstract][Full Text] [Related]
39. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
McCann LM; Beto J
J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
[TBL] [Abstract][Full Text] [Related]
40. The kidney as an endocrine organ involved in the function of vitamin D.
DeLuca HF
Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
